Role of Different Pre-Treatments on Composition and Rheology of Synovial Fluids

Polymers (Impact Factor: 2.51). 12/2009; DOI: 10.3390/polym1010016
Source: DOAJ

ABSTRACT Different pre-treatments applied to synovial fluids (SF) before their analyses are tested to characterize SF after storage under different conditions and to investigate their evolution along a viscosupplementation treatment. The main techniques proposed involve steric exclusion chromatography with triple detection (SEC) and viscometry; it is the first time that such a study is developed. SEC gives the molecular weight distribution and concentration of hyaluronan (HA) and proteins separately; the steady state viscosity is always non-Newtonian and not directly related to SF composition. Pre-treatment of SF (storage in cold, filtration, centrifugation) allows us to conclude that, in order to store SF, it is best to freeze it, even if in some cases, viscosity is modified but not the composition. All the data obtained (including protease pre-treatment) allow us to conclude that a small fraction of HA-protein complex forms a loose 3D-network and controls the rheology.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose Osteoarthritis (OA) is a degenerative joint disease that is characterized by the breakdown of articular cartilage. Rheology of synovial fluid is of interest because of its significance in joint lubrication. However, there are still many questions related to synovial fluid rheology and its relation with OA. Although viscosupplementation has been used as a treatment for OA for many years, its clinical effect remains controversial. Therefore, the purpose of this study is to determine in vitro the effect of different viscosupplements on the rheological properties of synovial fluid. Methods A detailed rheological characterization of synovial fluid from 26 patients undergoing total knee arthroplasty (TKA) was performed. The rheological properties of the osteoarthritic synovial fluid added with viscosupplements were compared with those of the healthy human synovial fluid in order to assess the restorative effect on naturally occurring synovial fluid within the joint. Furthermore, the stability of rheological properties of synovial fluid mixed with viscosupplements in vitro over 8 weeks was analyzed. Results The addition of a cross-linked viscosupplement to OA synovial fluid was found to be more efficient than linear ones in improving the overall rheological properties of synovial fluid. The findings indicate that the rheological properties of SF mixed with VSs changed over 8 weeks. Conclusions The findings from this study will lead to a better understanding of the role of viscosupplements in joint lubrication and OA.
    11/2011; 1(4). DOI:10.1007/s13534-011-0034-7
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The lubricating and structural properties of different mammalian synovial fluids in thin films undergoing shear between two mica surfaces are studied in detail using a surface force apparatus (SFA). A 10–13 nm thick film of synovial components (proteins, lipids, and polymers) adsorbs on the mica surfaces in less than an hour of incubation time, and induces a strong repulsion between the surfaces that prevents them from coming into contact. Upon shearing, the structure of the confined synovial fluid changes dramatically when sheared above a “critical” shear rate of about 2 s−1 (corresponding to approximately 40 nm s−1). Above this critical shear rate and up to at least 70 μm s−1, the proteins and biopolymers in the fluid gradually aggregate to form a homogenous gel layer on each mica surface. As shearing continues, the gel layer gradually breaks up into discrete/individual gel particles that can roll in the contact keeping the sheared surfaces far apart even under high compressive loads (pressure P ≈ 20 MPa). These particles eventually become elongated and finally behave as roller bearings. This mechanism is consistently observed for three mammalian synovial fluids and two types of surfaces suggesting that it actually occurs in articular joints and prostetic implants in vivo. The implications of these findings for joints and prosthetic implants structure and lubrication are discussed; in particular the formation and function of the lamina splendens.
    Advanced Functional Materials 06/2014; 24(21). DOI:10.1002/adfm.201302959 · 10.44 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Anti-tumor necrosis factor α (TNFα) drugs such as etanercept (ETN) have been mostly used in systemic treatment of rheumatoid arthritis. To eliminate the side effects in long-term treatments and to achieve a local sustained anti-inflammatory effect, a controlled drug delivery system is needed for anti-TNFα drugs. This study aims to develop novel injectable microcarriers of ETN that can provide long-term controlled release of this protein drug upon intra-articular application. In this study, poly(ε-caprolactone) (PCL) and its copolymer with poly(ethylene glycol), methoxypoly(ethylene glycol)-poly(ε-caprolactone)-methoxypoly(ethylene glycol) microspheres (MPEG-PCL-MPEG) were compared for their prospective success in rheumatoid arthritis treatment. Microspheres with smooth surface of a mean particle diameter of approximately 5 μm were prepared with both polymers. MPEG-PCL-MPEG microspheres had higher encapsulation efficiency than PCL microspheres. The activity of encapsulated ETN within MPEG-PCL-MPEG microspheres also retained while 90% of the activity of ETN within PCL microspheres could retain during 90-day release. MPEG-PCL-MPEG microspheres showed faster ETN release compared to PCL microspheres in various release media. Cumulative amounts of ETN released from both types of microspheres were significantly lower in cell culture medium and in synovial fluids than in phosphate buffered saline. This was mainly due to protein adsorption onto microspheres. Hydrophilic MPEG segment enhanced ETN release while preventing protein adsorption on microspheres compared to PCL. Sustained ETN release from microspheres resulted with a significant decrease in pro-inflammatory cytokines (TNFα, IFNγ, IL-6, IL-17) and MMP levels (MMP-3, MMP-13), while conserving viability of fibroblast-like synoviocytes compared to the free drug. Results suggest that MPEG-PCL-MPEG is a potential copolymer of PCL that can be used in development of biomedical materials for effective local treatment purposes in chronic inflammatory arthritis owing to enhanced hydrophilicity. Yet, PCL microspheres are also promising systems having good compatibility to synoviocytes and would be especially the choice for treatment approach requiring longer term and slower release.
    Journal of Biomaterials Applications 05/2014; 29:524. DOI:10.1177/0885328214535958 · 2.76 Impact Factor

Full-text (2 Sources)

Available from
May 22, 2014